Marcus Bryant
Story Poster
Detailing important departures from Texas A&M's top 2025 opponents
1 mo ago by Olin Buchanan
As Mike Elko & Co. prepare for the 2025 football season, Olin Buchanan takes a deep dive into the losses that some of Texas A&M's biggest opponents are facing due to players' completion of eligibility, early entry to the NFL draft and those entering the transfer portal.
Story Poster
Key Matchups: No. 25 Texas A&M vs. No. 9 Missouri
6 mo ago by Olin Buchanan
For the second time in four home games this season, College Station plays host to a top-25 showdown, and Week 6 is another pivotal matchup for the Aggies. Olin Buchanan details the in-game matchups he is keeping an eye on when No. 25 Texas A&M faces No. 9 Missouri.
Story Poster
Tale of the Tape: No. 25 Texas A&M vs. No. 9 Missouri
6 mo ago by TexAgs
Despite having a 4-0 record, Eli Drinkwitz and the ninth-ranked Missouri Tigers come to Kyle Field with a lot to prove as Mike Elko's No. 25 Aggies look to extend their winning streak to five straight. The top-25 showdown in Aggieland is the only ranked vs. ranked matchup in Week 6.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
11:57
Getting to know Drinkwitz's Tigers with Mizzou beat writer Jarod Hamilton
6 mo ago by David Nuño
Ahead of Saturday's matchup against the ninth-ranked Missouri Tigers, Missouri football beat writer and insider Jarod Hamilton joined Thursday morning's edition of TexAgs Live to preview what sort of challenges the Tigers will present Texas A&M.
Story Poster
Continued success for Missouri contingent on new-look defense
10 mo ago by Olin Buchanan
A high-caliber offense from last season remains mostly intact in Columbia despite running back Cody Schrader, who led the SEC in rushing yards, departing for the NFL. Before Missouri takes another step in its meteoric rise, the Tigers have some questions to answer defensively.
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.